Literature DB >> 2908298

Adrenergic receptor effects and antihypertensive actions of beta-adrenoceptor-blocking agents with ancillary properties.

S Imai1, H Nakahara, M Nakazawa, K Takeda.   

Abstract

The acute antihypertensive effects and possible underlying mechanisms of 3 beta-adrenergic-blocking drugs with alpha-blocking activity, i.e. labetalol, drugs with alpha-blocking activity, i.e. labetalol, nipradilol and arotinolol, were studied in conscious spontaneously hypertensive rats (SHR) and compared with the effects of prazosin, propranolol and hydralazine. Prazosin produced a dose-dependent antihypertensive effect which paralleled inhibition of the pressor response to phenylephrine. Labetalol (30 mg/kg), nipradilol (30 and 100 mg/kg) and arotinolol (30 and 100 mg/kg) also produced a fall in blood pressure. However, inhibition of the pressor response to phenylephrine was not seen in association with the antihypertensive effect after the lower dose of nipradilol and arotinolol. Propranolol (100 mg/kg) did not lower blood pressure. These results suggest that a mechanism(s) other than an alpha-adrenergic-blocking effect plays a role in the acute antihypertensive effects produced by the lower dose of nipradilol and arotinolol.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2908298     DOI: 10.2165/00003495-198800366-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  11 in total

1.  Routine direct measurement of arterial pressure in unanesthetized rats.

Authors:  J R WEEKS; J A JONES
Journal:  Proc Soc Exp Biol Med       Date:  1960 Aug-Sep

2.  Comparative assessment of beta-adrenoceptor blocking agents as simple competitive antagonists in isolated heart muscle: similarity of inotropic and chronotropic blocking potencies against isoproterenol.

Authors:  A J Kaumann; T K McInerny; D P Gilmour; J R Blinks
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-04       Impact factor: 3.000

3.  Heterogeneity of postsynaptic Alpha adrenergic receptors in mammalian aortas.

Authors:  R R Ruffolo; J E Waddell; E L Yaden
Journal:  J Pharmacol Exp Ther       Date:  1982-05       Impact factor: 4.030

4.  [Alpha- and beta-adrenoceptor blocking actions of labetalol and effects on the myocardial function, coronary circulation and myocardial energy metabolism thereof (author's transl)].

Authors:  Y Katano; K Takeda; Y Nakagawa; T Hashimoto; M Nakazawa; T Tsukada; T Otorii; S Imai
Journal:  Nihon Yakurigaku Zasshi       Date:  1978-10

5.  Hypotensive and vascular effects of labetalol in the normotensive rat and dog.

Authors:  K Hashimoto; T Hashimoto; H Iizuka; T Tsukada; H Matsuda; S Imai
Journal:  Jpn Heart J       Date:  1978-09

6.  [Antihypertensive effect of arotinolol (S-596), a new adrenergic beta blocking agent, on experimental hypertension].

Authors:  Y Hara; H Nakahara; A Miyagishi; H Nakatani
Journal:  Nihon Yakurigaku Zasshi       Date:  1983-08

7.  Effects of a new beta-adrenoceptor blocking agent, S-596 (arotinolol), on isolated dog coronary arteries.

Authors:  M Sakanashi; Y Miyamoto; S Takeo; K Noguchi
Journal:  Arch Int Pharmacodyn Ther       Date:  1983-06

8.  Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.

Authors:  Y Uchida; M Nakamura; S Shimizu; Y Shirasawa; M Fujii
Journal:  Arch Int Pharmacodyn Ther       Date:  1983-03

9.  The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats.

Authors:  G M Drew; A Hilditch; G P Levy
Journal:  Clin Exp Hypertens       Date:  1979       Impact factor: 1.749

10.  Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.

Authors:  A Miyagishi; H Nakahara; Y Hara
Journal:  Arch Int Pharmacodyn Ther       Date:  1984-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.